Drug

Why Amgen’s Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New EnemyWhy Amgen’s Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemy

After the Federal Trade Commission (FTC) demanded Bristol-Myers Squibb (NYSE:BMY) sell its blockbuster Otezla to secure approval for its $74 billion acquisition of Celgene (NASDAQ:CELG), a bidding war resulted in Amgen (NASDAQ:AMGN) agreeing

Intelligence

Artificial Intelligence (AI) Stats News: AI Augmentation To Create $2.9 Trillion Of Business ValueArtificial Intelligence (AI) Stats News: AI Augmentation To Create $2.9 Trillion Of Business Value

The recent surveys, studies, forecasts and other quantitative assessments of the health and progress of AI estimated the impact on productivity of human-machine collaboration, the